UK markets closed
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.85 -0.72 (-0.93%) GOLD FUTURES
2,334.80 -58.10 (-2.43%) DOW
39,060.29 -610.75 (-1.54%) Bitcoin GBP
53,016.52 -1,754.02 (-3.20%)
Ono Pharmaceutical Co., Ltd. (ON4.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 6.23B |
| Enterprise value | 5.08B |
| Trailing P/E | 8.27 |
| Forward P/E | 13.50 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.11 |
| Price/book (mrq) | 1.31 |
| Enterprise value/revenue | 1.71 |
| Enterprise value/EBITDA | 4.73 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.20 |
| 52-week change 3 | -23.98% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 18.20 |
| 52-week low 3 | 13.00 |
| 50-day moving average 3 | 14.25 |
| 200-day moving average 3 | 15.81 |
Share statistics
| Avg vol (3-month) 3 | 70 |
| Avg vol (10-day) 3 | 55 |
| Shares outstanding 5 | 469.65M |
| Implied shares outstanding 6 | 479.31M |
| Float 8 | 453.32M |
| % held by insiders 1 | 15.55% |
| % held by institutions 1 | 46.82% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.48 |
| Forward annual dividend yield 4 | 3.70% |
| Trailing annual dividend rate 3 | 80.00 |
| Trailing annual dividend yield 3 | 615.38% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 30.01% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 27 Sept 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 25.46% |
| Operating margin (ttm) | 13.58% |
Management effectiveness
| Return on assets (ttm) | 11.13% |
| Return on equity (ttm) | 16.56% |
Income statement
| Revenue (ttm) | 502.67B |
| Revenue per share (ttm) | 1,047.21 |
| Quarterly revenue growth (yoy) | 4.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 178.07B |
| Net income avi to common (ttm) | 127.98B |
| Diluted EPS (ttm) | 1.57 |
| Quarterly earnings growth (yoy) | 2.10% |
Balance sheet
| Total cash (mrq) | 204.6B |
| Total cash per share (mrq) | 435.64 |
| Total debt (mrq) | 8.86B |
| Total debt/equity (mrq) | 1.11% |
| Current ratio (mrq) | 3.99 |
| Book value per share (mrq) | 1,688.42 |
Cash flow statement
| Operating cash flow (ttm) | 110.66B |
| Levered free cash flow (ttm) | 49.81B |
© 2024 Yahoo. All rights reserved.